Summary
Recent laws and regulations reflect the regulators’ restrictive position towards Import FIEs’ distribution rights and the provision of drug information by ROs.
This Newsletter analyzes the key regulatory changes and their consequences on Pharmaceuticals MNCs’ business operations in Vietnam.
